Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
Open Access
- 8 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (13) , 1255-1261
- https://doi.org/10.1093/eurheartj/ehi230
Abstract
Aims The study evaluated the associations between glycometabolic parameters at admission and during hospitalization and 2 year all-cause mortality risk in an unselected cohort of consecutive patients with diabetes admitted for unstable angina or non-Q-wave myocardial infarction to a university hospital during 1988–98. Methods and results A total of 713 consecutive patients with diabetes were included. During 2 years of follow-up, 242 (34%) patients died. All analyses were retrospective using prospectively collected clinical data. The primary study endpoint was 2 year all-cause mortality collected from the Swedish cause-specific mortality register. In unadjusted analyses, high admission blood glucose (highest vs. lowest quartile: hazard ratio (HR) 2.66; 95% confidence interval (CI) 1.83, 3.86) and hypoglycaemia recorded during hospitalization (hypoglycaemia vs. normal: HR 1.77; 95% CI 1.09, 2.86) were both significantly associated with increased 2 year all-cause mortality risk. These associations remained significant after multivariable adjustment. Conclusion In the setting of acute coronary syndromes (ACS) among patients with diabetes, hyperglycaemia on arrival and hypoglycaemia during hospitalization are both independently associated with worse adjusted all-cause 2 year mortality risk. These observations suggest that the avoidance of both hyper- and hypoglycaemia during ACS events may be of similar importance, and glucose modulation remains an important objective to address in future randomized trials.Keywords
This publication has 22 references indexed in Scilit:
- 827-3 Women with diabetes mellitus have the greatest reduction in myocardial infarction mortality over the past decade: Evaluation of 1,428,596 patients enrolled in the national registry of myocardial infarction 2, 3, and 4 from 1994–2002Journal of the American College of Cardiology, 2004
- Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromesAmerican Heart Journal, 2004
- Influence of diabetes on long-term outcome among unselected patients with acute coronary events.Scandinavian Cardiovascular Journal, 2004
- A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromesHeart, 2003
- Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb StudyEuropean Heart Journal, 2000
- Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial InfarctionCirculation, 2000
- Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.Diabetes Care, 1999
- Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projectionsDiabetes Care, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993